Pendium
RoadmapPricing
Get a demo
Dashboard
Dashboard
Loading…
/

Teach AI agents to recommend your brand to the right people.

Scan your visibilityBook a demo
Pendium
𝕏

Product

AI Visibility ScanYelp Listing AuditSite AuditContent for AI AgentsAgent Experience EngineAgent AnalyticsPricing

Industries

Local BusinessesRestaurantsHome ServicesBeauty & SpasHealth & MedicalFitness & GymsPet ServicesContractorsBars & NightlifeMoving CompaniesAuto DealershipsSaaS CompaniesSEO TeamsMarketing Teams

Tools

AI Visibility Site ScanYelp Listing AuditGBP AuditSocial Presence AuditBlog That Writes Itself

Real Life Examples

RipplingMasterclassThorneMonday.comPatagonia

Company

AboutResearchBook a DemoDocsPrivacy PolicyTerms of Service
© 2026 Manifest Labs. All rights reserved.
PrivacyTerms
Amgen Inc.
Amgen Inc.
Visibility47
Vibe86

This is a preview of our capabilities. To see the full results across all LLMs, run a full scan.

Businesses/Biotechnology / Healthcare/Amgen Inc.
Amgen Inc.
AI Visibility & Sentiment

Amgen Inc.

Amgen is a global biopharmaceutical leader dedicated to discovering and manufacturing innovative human therapeutics for serious illnesses. By leveraging advanced human genetics and biotechnology, the company addresses significant medical needs in oncology, cardiovascular disease, and rare conditions.

Active Monitoring
amgen.com
Biotechnology / Healthcare
Partial scan
AI Visibility Score
47/100

Moderate

Sentiment Score
86/100
Score by Priority

How often this business is recommended to users across different types of conversations — from direct product queries to broader open-ended conversations where AI could recommend this company's products and services

core
47
adjacent
69
aspirational
91
OverviewLandscapeInsights & ActionsConversationsCitations

Is this your business?

AI Perception

Key Takeaways

How AI platforms collectively perceive and describe Amgen Inc. today.

Amgen commands strong authority in institutional reputation and high-level category trust, effectively securing top-tier positions when users inquire about industry leadership. However, there is a critical disconnect between this corporate brand strength and product-specific visibility, where Amgen often fails to appear during high-intent clinical decision-making queries.

Working in your favor

Securing #1 and #2 positions for category trust and industry reputation queries in AI Overviews.

Effective presence in patient support program discussions, ranking #3 for queries regarding advanced assistance resources.

Resonant branding with the chronically ill patient advocate persona, achieving an average position of 1.0.

Gaps to close

Complete absence in specific therapeutic selection queries, particularly regarding biologics management and injectable LDL cholesterol treatments.

Lack of visibility in clinical-focused queries for oncology support, where competitors consistently outrank Amgen.

Underperformance in biosimilar vs. originator comparison queries, where the brand should hold clear thought leadership.

Opportunities

Capitalize on existing institutional trust to bridge the gap into clinical therapeutic selection content.

Develop dedicated content addressing the mechanics of biosimilar advantages to capture searchers currently not seeing Amgen in comparative research.

Optimize technical medical content to better align with the language used by clinical oncology and pharmacy procurement decision-makers.

Highest-Impact Actions
1

Develop and deploy clinical-grade, decision-support content specifically mapped to the biologic and LDL cholesterol management queries.

Amgen has brand trust but is losing the 'last mile' of the decision-making process by failing to appear in therapeutic selection searches.

2

Create authoritative white papers or clinical comparisons on biosimilars versus originator biologics.

These queries represent high-intent research by healthcare professionals and purchasers where Amgen is currently absent, despite its market position.

3

Optimize oncology support web architecture to explicitly feature Amgen's patient support programs.

Competitors are successfully leveraging support-centric language to dominate patient-focused search results; strengthening this signal will improve visibility with advocates.

Value Proposition

Amgen utilizes a 'Biology First' approach, combining protein engineering expertise with large-scale manufacturing to produce complex biologic medicines with a high-reliability supply chain.

Overview

Amgen is a global biopharmaceutical leader dedicated to discovering and manufacturing innovative human therapeutics for serious illnesses. By leveraging advanced human genetics and biotechnology, the company addresses significant medical needs in oncology, cardiovascular disease, and rare conditions.

Mission

To serve patients by transforming the promise of science and biotechnology into therapies that have the power to restore health or save lives.

Products & Services
Enbrel (etanercept)Prolia (denosumab)Repatha (evolocumab)Otezla (apremilast)Blincyto (blinatumomab)
Current State

Visibility Landscape

A high-level view of how Amgen Inc. performs across AI platforms, broken down by strategic priority level — from core brand queries to growth opportunities.

ChatGPTChatGPT
ClaudeClaude
GeminiGemini
AI OverviewsAI Overviews

Reputation1q

Sentiment when asked about the brand directly

—
—
—
100
“What do you know about Amgen Inc.? What do they do and what's their reputation?”
—
—
—
Positive

Core3q

Product/service category queries

—
—
—
47
“what are the most effective biologic options for managing moderate to severe plaque psoriasis besides standard topicals”
—
—
—
#11
“compare leading injectable treatments for lowering LDL cholesterol for patients who cannot tolerate statins”
—
—
—
Yes
“what are the best long-term bone density treatments for postmenopausal osteoporosis that are administered via injection”
—
—
—
Yes

Growth Areas5q

Adjacent, aspirational & visionary

—
—
—
63
“which biopharmaceutical companies are best known for high-reliability manufacturing of complex protein therapeutics”
—
—
—
#1
“recommend supportive care platforms or drug resources for patients undergoing intensive immunotherapy for acute lymphoblastic leukemia”
—
—
—
#7
“what should I look for when comparing biosimilars versus original biologic therapies for chronic autoimmune conditions”
—
—
—
No
“what are the most reputable biotech firms developing new immunotherapy agents for aggressive oncology cases”
—
—
—
—
“what are the most advanced patient support programs provided by pharmaceutical companies for people on long-term biologic therapy”
—
—
—
#3
ChatGPT
Claude
Gemini
AI Overviews

“What do you know about Amgen Inc.? What do they do and what's their reputation?”

ChatGPT—
Claude—
Gemini—
AI OverviewsPositive

“what are the most effective biologic options for managing moderate to severe plaque psoriasis besides standard topicals”

ChatGPT—
Claude—
Gemini—
AI Overviews#11

“compare leading injectable treatments for lowering LDL cholesterol for patients who cannot tolerate statins”

ChatGPT—
Claude—
Gemini—
AI OverviewsYes

“what are the best long-term bone density treatments for postmenopausal osteoporosis that are administered via injection”

ChatGPT—
Claude—
Gemini—
AI OverviewsYes

“which biopharmaceutical companies are best known for high-reliability manufacturing of complex protein therapeutics”

ChatGPT—
Claude—
Gemini—
AI Overviews#1

“recommend supportive care platforms or drug resources for patients undergoing intensive immunotherapy for acute lymphoblastic leukemia”

ChatGPT—
Claude—
Gemini—
AI Overviews#7

“what should I look for when comparing biosimilars versus original biologic therapies for chronic autoimmune conditions”

ChatGPT—
Claude—
Gemini—
AI OverviewsNo

“what are the most reputable biotech firms developing new immunotherapy agents for aggressive oncology cases”

ChatGPT—
Claude—
Gemini—
AI Overviews—

“what are the most advanced patient support programs provided by pharmaceutical companies for people on long-term biologic therapy”

ChatGPT—
Claude—
Gemini—
AI Overviews#3
Brand Ecosystem
1
Amgen Inc.
7 mentions
2
Novo Nordisk A/S
4 mentions
3
WuXi Biologics
4 mentions
4
Bimzelx
3 mentions
5
Skyrizi
3 mentions
6
Taltz
3 mentions
7
Tremfya
3 mentions
8
Cosentyx
3 mentions
9
Cancer Support Community
cancersupportcommunity.org
3 mentions
10
Samsung Biologics
3 mentions
11
Reclast
3 mentions
Analysis

Insights & Recommended Actions

What's working, what's not, and specific steps to improve Amgen Inc.'s AI visibility.

Key Findings

Strength

Securing #1 and #2 positions for category trust and industry reputation queries in AI Overviews.

Strength

Effective presence in patient support program discussions, ranking #3 for queries regarding advanced assistance resources.

Strength

Resonant branding with the chronically ill patient advocate persona, achieving an average position of 1.0.

Recommended Actions

1

Develop and deploy clinical-grade, decision-support content specifically mapped to the biologic and LDL cholesterol management queries.

Amgen has brand trust but is losing the 'last mile' of the decision-making process by failing to appear in therapeutic selection searches.

2

Create authoritative white papers or clinical comparisons on biosimilars versus originator biologics.

These queries represent high-intent research by healthcare professionals and purchasers where Amgen is currently absent, despite its market position.

3

Optimize oncology support web architecture to explicitly feature Amgen's patient support programs.

Competitors are successfully leveraging support-centric language to dominate patient-focused search results; strengthening this signal will improve visibility with advocates.

Programmatic Testing

Sample Conversations

We programmatically analyze questions that real customers are asking to AI agents and chatbots, extract brand mentions and sentiment, analyze every response, and synthesize the data into an action plan to increase AI visibility.

ChatGPTChatGPTClaudeClaudeGeminiGeminiAI OverviewsAI Overviews
Therapeutic Selection And Condition Management(3 queries)

“what are the most effective biologic options for managing moderate to severe plaque psoriasis besides standard topicals”

0/1 platforms mentioned

Core
AI OverviewsAI Overviews
1.Bimzelx
2.Skyrizi
3.Taltz
4.Tremfya
5.Cosentyx

+1 more

“compare leading injectable treatments for lowering LDL cholesterol for patients who cannot tolerate statins”

0/1 platforms mentioned

Core
Clinical Oncology Specialist · Buyer
AI OverviewsAI Overviews
1.Evkeeza

“what are the best long-term bone density treatments for postmenopausal osteoporosis that are administered via injection”

1/1 platforms mentioned

Core
Clinical Oncology Specialist · Buyer
AI OverviewsAI Overviews
1.Reclast
2.Evenity
3.Forteo
4.Tymlos
5.Boniva
Source Intelligence

Citations

The sources AI platforms cite when recommending this brand. Pendium reverse-engineers what's already proven to be catnip to AI agents, then engineers content that fills gaps and helps agents do their job — which means more citations for you.

Psoriasis Treatment in 2025: More Options, Better Outcomes

practicaldermatology.com

Web1 ref

Psoriasis - Diagnosis and treatment - Mayo Clinic

mayoclinic.org

Web1 ref

Which Biologic is Best for Psoriasis Treatment? - EMJ

emjreviews.com

Web1 ref

Biologic Treatment Algorithms for Moderate-to-Severe ... - PMC

pmc.ncbi.nlm.nih.gov

Gov1 ref

Psoriasis in 2025: Year in Review - HCPLive

hcplive.com

Web1 ref

11 Biologic Medications for Psoriasis Treatment - WebMD

webmd.com

Web1 ref

Tolerability and comparative effectiveness of TNF, IL-17 and IL ...

pubmed.ncbi.nlm.nih.gov

Gov1 ref

TNF-Alpha Inhibitors and Ustekinumab for the Treatment of Psoriasis

pmc.ncbi.nlm.nih.gov

Gov1 ref

The TNF/IL‐23/IL‐17 axis—Head‐to‐head trials comparing ...

onlinelibrary.wiley.com

Web1 ref

IL-17 vs. IL-23: The Latest Comparison

thedermdigest.com

Web1 ref

Dermatology Times 2025 Year in Review: Psoriasis

dermatologytimes.com

Web1 ref

Therapeutic Advances in Psoriasis: From Biologics to Emerging Oral ...

pmc.ncbi.nlm.nih.gov

Gov1 ref

Phase 3 Results Signal a New Era for Oral Targeted Therapy in ...

dermatologytimes.com

Web1 ref

Systemic Pharmacologic Treatments for Plaque Psoriasis | AAFP

aafp.org

Web1 ref

Biologics for Psoriasis - Everything You Need to Know

psoriasis.org

Web1 ref

Engineer content that makes AI agents recommend you

Pendium analyzes how AI platforms perceive your brand, reverse-engineers what they already cite, and continuously publishes content designed to fill gaps and earn more mentions — on autopilot, with you in the loop.

Data generated by Pendium.ai AI visibility scanning. Last scanned March 16, 2026.

Start getting
recommended by AI.

Enter your website to see exactly what ChatGPT, Claude, and Gemini say about your business. Free, instant, and eye-opening.

Free visibility scanResults in 2 minutesNo credit card required

Frequently asked questions

Don't see your question? Book a demo and we'll walk you through it.

Amgen is a global biopharmaceutical leader dedicated to discovering and manufacturing innovative human therapeutics for serious illnesses. By leveraging advanced human genetics and biotechnology, the company addresses significant medical needs in oncology, cardiovascular disease, and rare conditions.

Amgen utilizes a 'Biology First' approach, combining protein engineering expertise with large-scale manufacturing to produce complex biologic medicines with a high-reliability supply chain.

AI Visibility Score

Amgen Inc. has an AI visibility score of 59/100, rated as moderate. This score reflects how often and how prominently Amgen Inc. appears in responses from AI assistants like ChatGPT, Claude, and Gemini.

AI Perception Summary

Amgen commands strong authority in institutional reputation and high-level category trust, effectively securing top-tier positions when users inquire about industry leadership. However, there is a critical disconnect between this corporate brand strength and product-specific visibility, where Amgen often fails to appear during high-intent clinical decision-making queries.

Strengths

  • Securing #1 and #2 positions for category trust and industry reputation queries in AI Overviews.
  • Effective presence in patient support program discussions, ranking #3 for queries regarding advanced assistance resources.
  • Resonant branding with the chronically ill patient advocate persona, achieving an average position of 1.0.

Visibility Gaps

  • Complete absence in specific therapeutic selection queries, particularly regarding biologics management and injectable LDL cholesterol treatments.
  • Lack of visibility in clinical-focused queries for oncology support, where competitors consistently outrank Amgen.
  • Underperformance in biosimilar vs. originator comparison queries, where the brand should hold clear thought leadership.

Competitors in AI Recommendations

  • Novo Nordisk A/S: 4 mentions
  • WuXi Biologics: 4 mentions
  • Bimzelx: 3 mentions
  • Skyrizi: 3 mentions
  • Taltz: 3 mentions
  • Tremfya: 3 mentions
  • Cosentyx: 3 mentions
  • Cancer Support Community: 3 mentions
  • Samsung Biologics: 3 mentions
  • Reclast: 3 mentions
  • Evenity: 3 mentions
  • Forteo: 3 mentions
  • Tymlos: 3 mentions
  • Sotyktu: 2 mentions
  • Regeneron Pharmaceuticals: 2 mentions

Categories: Biotechnology / Healthcare